Navigation Links
Global Transdermal Drug Delivery Market 2014-2018: Key Vendors are ANI Pharmaceuticals, Antares Pharma, Bayer, Janssen and Novartis
Date:8/7/2014

DUBLIN, Aug. 7, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Transdermal Drug Delivery Market 2014-2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Transdermal drug delivery is a large and growing vertical market of the Pharmaceutical industry. Transdermal drug delivery is defined as a system that utilizes skin as a site for continuous drug administration into the systemic circulation. Several methods of transdermal drug delivery include plasters, various ointments and, most commonly, patches. Transdermal drug administration has several advantages.

First, the method of delivery is non-invasive, which is much less traumatic to the patient as compared to other forms of drug delivery. Also, it can be effective in assuring that a patient receives a full dosage of a drug and helps in increasing the compliance rate. However, there are difficulties associated with administering medication through the skin. The natural function of the skin is to act as a protective barrier, so it is often the case that drugs are not chemically suitable to penetrating the skin.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Competitive Assessment of Transdermal Drugs Delivery Market

08. Optimisation of Transdermal Drug Delivery

09. Market Segmentation by Application

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

20. Other Reports in this Series

Companies Mentioned:

  • ANI Pharmaceuticals Inc.
  • Antares Pharma Inc.
  • Bayer AG
  • Janssen Pharmaceuticals Inc.
  • Novartis AG
  • 3M Pharmaceuticals Co.
  • Durect Corp.
  • Iontera Inc.
  • Isis Biopolymer Inc.
  • LTS Lohmann Therapie-Systeme AG
  • Mylan Laboratories Inc.
  • Nitto Denko Corp.
  • Pantec Biosolutions AG
  • Phosphagenics Ltd.
  • Tesa Labtec GmbH
  • Teva Pharmaceutical Industries Ltd.

For more information visit http://www.researchandmarkets.com/research/dj2pc6/global

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Hemoglobin A1c Testing Devices (Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay) Market - Forecast to 2019
2. Global Safety Syringes (Automatic Retractable Safety Syringes, Manual Retractable Safety Syringes, Non-Retractable Safety Syringes) Market - Forecast to 2019
3. Enteral Feeding Devices Market (Enteral Feeding Tubes, Enteral Feeding Pumps, Administration Reservoir, Giving Sets and Enteral Syringes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
4. Orthopedic Soft Tissue Repair Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
5. Antibacterial Drugs Market (By Class and Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
6. Global Digital X-ray (Floor to ceiling mounted, Ceiling mounted, Handheld) Market - Forecast to 2018
7. Global Patient Safety Highlighted by NABP, Domestic and International Stakeholders at .Pharmacy Supporter Advisory Committee Meeting
8. Myalgia Global Clinical Trials Review, H2, 2014
9. Myoclonus Global Clinical Trials Review, H2, 2014
10. Neuralgia Global Clinical Trials Review, H2, 2014
11. Multiple Sclerosis Global Clinical Trials Review, H2, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... --  Risperdal lawsuits involving gynecomastia (male breast growth) ... the atypical antipsychotic medication continue to move forward in ... Pleas, where the state,s Risperdal docket has been centralized ... posted on the Court,s website , the litigation ... 2017 at 11:00 a.m. (In Re: Risperdal Litigation, Case ...
(Date:2/17/2017)... NEW YORK , Feb. 17, 2017 /PRNewswire/ ... announced today the partnership of their 3D body ... in healthcare IT.  The new integration will be ... on an interactive model of the human body. ... data saves clinicians time, while also increasing the ...
(Date:2/16/2017)... , Feb. 16, 2017 Research and ... for Emerging Medical Device Technologies" report to their offering. ... ... open procedures, general instruments, non-drug coated implantables, large endoscopes, needle ... in use over the last two to three decades for ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... Like most hospitals across ... Driven in large part by the Hospital Readmission Reduction Program (HRRP), the return of ... focus area for hospitals across the nation. While many providers are struggling to leverage ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Mason ... to families and business owners in and around the Hampton Roads metropolitan region, ... prevent all forms of domestic violence. , There are multiple categories of domestic ...
(Date:2/16/2017)... ... February 17, 2017 , ... Harsha ... 10 years of research, development and clinical trials, the founder of Chigurupati Technologies ... patented compound of FDA approved ingredients that when infused into alcohol, protect the ...
(Date:2/16/2017)... ... 17, 2017 , ... Teaching nursing care of vulnerable children is the focus ... is being created with the support of the Hearst Foundations. An initiative of the ... address what has been identified as a critical gap in preparing the next generation ...
(Date:2/16/2017)... (PRWEB) , ... February 16, 2017 , ... ... nursing professionalism, teamwork and superiority in patient care, NWH has achieved Magnet® ... on Magnet on Tuesday, January 31, 2017. The American Nurses Credentialing Center’s Magnet ...
Breaking Medicine News(10 mins):